GraniteShares Advisors’s ResMed RMD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$452K Sell
2,320
-176
-7% -$36.5K 0.29% 76
2026
Q1
$560K Sell
2,496
-431
-15% -$107K 0.4% 69
2025
Q4
$705K Buy
2,927
+350
+14% +$89.5K 0.43% 73
2025
Q3
$705K Sell
2,577
-91
-3% -$24.9K 0.41% 70
2025
Q2
$688K Sell
2,668
-50
-2% -$11.9K 0.42% 70
2025
Q1
$608K Sell
2,718
-57
-2% -$13.3K 0.39% 69
2024
Q4
$635K Buy
+2,775
New +$668K 0.4% 71
2023
Q4
Sell
-4,001
Closed -$592K 108
2023
Q3
$592K Buy
+4,001
New +$723K 0.55% 72
2022
Q1
Sell
-691
Closed -$179K 270
2021
Q4
$179K Buy
+691
New +$179K 0.08% 203

Other funds holding RMD

GraniteShares Advisors's RMD Position: Q2 2026 in Review

GraniteShares Advisors reduced its ResMed (RMD) stake by 7.1% in Q2 2026, selling an estimated $36.5K and leaving 2,320 shares worth $452K. The position accounts for 0.29% of the portfolio, ranked #76.

GraniteShares Advisors first reported a position in RMD in Q4 2021 and has held it in 9 quarters since. The position peaked at $705K in Q3 2025. 887 funds tracked by Wall St. Rank hold RMD as of Q2 2026.

  • GraniteShares Advisors held 2,320 shares of ResMed worth $452K as of Q2 2026.
  • GraniteShares Advisors sold 176 ResMed shares in Q2 2026, an estimated $36.5K.
  • ResMed made up 0.29% of GraniteShares Advisors's portfolio in Q2 2026, its #76 holding.
  • GraniteShares Advisors first reported a position in ResMed in Q4 2021 and has held it in 9 quarters since.
  • GraniteShares Advisors's ResMed position peaked at $705K in Q3 2025.
  • 887 funds tracked by Wall St. Rank held ResMed as of Q2 2026.

Based on GraniteShares Advisors's 13F filing for Q2 2026, filed 4 Aug 2026.